• SENSEX 82,726.64
    539.83 (+0.66%)
  • BANKNIFTY 56,756.00
    -196.75 (--0.35%)
  • Oberoi Realty
    1,751.00 1,440.05(%)
  • Canara Bank
    106.35 78.58(%)
  • SpiceJet
    40.84 79.90(%)
  • Lodha Developers
    1,330.55 1,036.00(%)
  • Havells India
    1,549.05 1,360.05(%)
  • ICICI Bank
    1,489.95 1,482.00(%)
  • One 97
    1,090.00 1,063.00(%)
  • Bombay Dyeing
    190.85 256.25(%)
  • Ola Electric
    43.95 157.53(%)
  • Dixon Technolog.
    16,671.15 19,149.80(%)
  • Anthem Bioscienc
    765.00 752.50(%)
  • Eternal Ltd
    303.60 311.60(%)
  • Paradeep Phosph.
    205.60 193.15(%)
  • Pidilite Inds.
    2,900.75 2,620.15(%)
  • Reliance Industr
    1,426.90 1,551.00(%)
  • I R F C
    136.90 209.10(%)
  • St Bk of India
    825.00 895.30(%)
  • Waaree Energies
    3,199.00 3,740.75(%)
  • Jayaswal Neco
    43.10 55.34(%)
  • Tata Motors
    692.95 1,179.05(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Divis Laboratories Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 21188.0
  • ISIN : INE361B01024
6,613.00 -75 (-1.12%)
  • As on 23 Jul 2025 (EOD)
  • Today’s Low

    6,579.50
  • Today’s High

    6,685.00
  • Open

    6,685.00
  • Perv Close

    6,688.00
  • 52W Low

    4,395.30
  • 52W High

    7,071.50

Key Indicators

  • P/E(TTM)

    79.48

  • Mar.Cap (₹Cr.)

    175,554.37

  • Div & Yield %

    0.45

  • Book Value(₹)

    561.09

  • Debt-Equity Ratio

    -1.12

  • AGM Date

    22-Jul-2025

  • EPS

    83.18

  • P/E Ratio

    79.48

Financials Ratios

  • Debt-Equity Ratio

    0.00

  • Mar.Cap (₹Cr.)

    175,554.37

  • RONW (%)

    12.15

  • ROCE (%)

    16.41

Score Board

  • Equity (₹ in Cr.)

    53.09

  • BV (₹)

    561.10

  • Sales( ₹ in Cr.)

    9,198.00

  • NP (in Cr.)

    2,208.27

  • NP Var(%)

    40.0

  • Div%

    1500.0

  • CPS (₹)

    98.30

  • EPS (₹)

    83.20

  • Traded Value (₹ in Lakhs)

    175,509.24

  • 52 Week High

    7,071.50

  • 52 Week Low

    4,395.30

  • Price BSE

    6611.0

  • Price NSE

    6,613.00

  • Market Capital( in Cr.)

    175,509.24

  • P/C Ratio

    67.30

  • P/E Ratio

    79.50

  • Price Vs.BV

    83.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 9,198.00 7,665.00 7,625.00 8,879.82 6,798.61 5,310.57
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 9,198.00 7,665.00 7,625.00 8,879.82 6,798.61 5,310.57
Other Income 352.00 337.00 349.00 111.26 62.53 189.86
Stock Adjustments 83.00 127.00 -50.00 449.99 100.00 94.10
Total Income 9,633.00 8,129.00 7,924.00 9,441.07 6,961.14 5,594.53
EXPENDITURE :            
Raw Materials 3,827.00 3,270.00 3,035.00 3,499.18 2,416.47 2,223.95
Power and Fuel Cost 465.00 477.00 496.00 390.05 319.15 280.73
Employee Cost 1,210.00 1,067.00 953.00 926.55 808.68 608.36
Other Manufacturing Expenses 276.00 299.00 285.00 255.38 202.29 184.36
Selling and Administration Expenses 449.00 367.00 402.00 340.16 292.53 222.86
Miscellaneous Expenses 74.00 137.00 55.00 40.95 37.69 68.00
Employee Benefit Expenses 1,210.00 1,067.00 953.00 926.55 808.68 608.36
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 6,301.00 5,617.00 5,226.00 5,452.27 4,076.81 3,588.26
Operating Profit 3,332.00 2,512.00 2,698.00 3,988.80 2,884.33 2,006.27
Interest 2.00 4.00 2.00 1.73 1.81 7.03
Gross Profit 3,330.00 2,508.00 2,696.00 3,987.07 2,882.52 1,999.24
Depreciation 401.00 376.00 342.00 310.55 254.65 185.95
Profit Before Tax 2,929.00 2,132.00 2,354.00 3,676.52 2,627.87 1,813.29
Current Tax 793.00 511.00 438.00 637.20 609.05 387.79
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -73.00 45.00 108.00 90.78 64.10 52.79
Reported Net Profit 2,209.00 1,576.00 1,808.00 2,948.54 1,954.72 1,372.71
Extraordinary Items 0.73 0.74 3.07 -1.65 -2.45 41.46
Adjusted Net Profit 2,208.27 1,575.26 1,804.93 2,950.19 1,957.17 1,331.25
Adjustment below Net Profit -2.00 -1.00 2.00 2.18 0.16 -92.52
P & L Balance brought forward 11,725.00 10,922.00 9,967.00 7,588.31 5,814.44 5,636.87
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 575.00 772.00 855.00 571.50 181.01 1,102.62
P & L Balance carried down 13,357.00 11,725.00 10,922.00 9,967.53 7,588.31 5,814.44
Dividend 0.00 0.00 0.00 0.00 0.00 424.75
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 1,500.00 1,500.00 1,500.00 1,500.00 1,000.00 800.00
Dividend Per Share(Rs) 30.00 30.00 30.00 30.00 20.00 16.00
Earnings Per Share-Unit Curr 83.36 59.47 68.23 111.08 73.64 51.71
Earnings Per Share(Adj)-Unit Curr 83.36 59.47 68.23 111.08 73.64 51.71
Book Value 562.08 508.83 479.43 440.44 349.28 275.63
Book Value(Adj)-Unit Curr 562.08 508.83 479.43 440.44 349.28 275.63

Shareholding Pattern

  • Promoter Group

    51.89%

  • Public Share Holding

    48.11%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 8,000,000 3.01 8,000,000 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 129,745,090 48.87 129,745,090 5
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 137,745,090 51.89 137,745,090 6
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 2,492 0.00 2,492 3
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 74,325 0.03 74,325 5
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 52,401,698 19.74 52,401,698 875
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 13,545,730 5.10 13,545,730 29
Mutual Funds / UTI 35,336,804 13.31 35,336,804 41
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,615,281 0.61 1,615,281 37
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 102,976,330 38.79 102,976,330 990
2] Non Institution
Bodies Corporate 3,331,978 1.26 3,331,978 1,945
Clearing Members 5,269 0.00 5,269 9
Directors of their Relatives 798,881 0.30 798,881 12
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,303,967 0.49 1,303,967 10,280
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 307,945 0.12 307,945 3,406
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 1,286,500 0.48 1,286,500 7
Individuals holding nominal share capital up to Rs. 1 lakh 17,435,638 6.57 17,361,227 243,130
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 249,694 0.09 249,694 37
Others 27,288 0.01 27,288 3
Sub Total 24,747,160 9.32 24,672,749 258,829
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 265,468,580 100.00 265,394,169 259,825

Company Background

Divis Laboratories LtdPharmaceuticals - Indian - Bulk Drugs

  • Divis Laboratories Ltd
  • BSE Code : 21188.0
  • ISIN : INE361B01024
  • Incorporation Year

    1990

  • Registered Office

    1-72-23(P)/DIVIS/303 Divi Towe
    Cyber Hills Gachibowli, Hyderabad,
    Telangana-500032

  • Telephone

    91-40-23786300/23786352/400

  • FAX

    91-40-23786460

  • Chairman

    Ramesh B V Nimmagadda

  • Managing Director

    Murali K Divi

  • Company Secretary

    Satish Choudhury

  • Auditor

    Price Waterhouse Chartered Accountants LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Divis Laboratories Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Divi's Lab. 6,611.30 9,550.00 9,198.00 79.45 20.63
Abbott India 34,192.50 6,684.73 6,409.15 51.37 44.95
Astrazeneca Phar 9,002.30 1,330.33 1,295.53 194.43 33.26
P & G Health Ltd 5,861.90 1,166.89 1,151.26 38.74 39.76
Glaxosmi. Pharma 3,098.40 3,866.05 3,723.49 57.11 58.72
Cipla 1,465.00 20,029.57 19,044.85 22.94 21.40
Amrutanjan Healt 699.55 437.58 421.23 39.79 20.84
Fermenta Biotec. 386.95 442.21 430.53 16.85 17.61
Guj. Themis Bio. 372.80 174.19 169.82 83.21 44.82
Bliss GVS Pharma 158.55 703.42 667.20 24.24 9.16
Ambalal Sarabhai 35.11 19.33 4.04 32.51 2.10